The global protein coupled receptor market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing demand for protein coupled receptors in various applications such as cardiovascular system, central nervous system, respiratory system, immune system and reproductive system. The global protein coupled receptor market by type includes calcium level detection assays, GTP?S binding assays, cGMP assays, reporter gene assays and receptor internalization assays. The application segment includes cardiovascular system (30%), central nervous system (25%), respiratory system (20%), immune systems (15%) and reproductive systems (10%). North America dominates the global protein coupled receptor market with a share of 40%. Europe follows with a share of 30%. Asia Pacific has a share of 25% followed by Latin America with 10%. Middle East & Africa has a share of 5%.
Some Of The Growth Factors Of This Market:
- The G-protein coupled receptor market is driven by the increasing prevalence of chronic diseases such as diabetes, obesity, and cardiovascular diseases.
- Increasing research and development activities in the field of biotechnology are also driving the growth of this market.
- Increasing awareness about the benefits associated with these drugs will also drive this market.
- The introduction of new drugs in this segment will also fuel its growth.
Industry Growth Insights published a new data on “G-protein Coupled Receptor Market”. The research report is titled “G-protein Coupled Receptor Market research by Types (Calcium Level Detection Assays, GTP?S Binding Assays, cGMP Assays, Reporter Gene Assays, Receptor Internalization Assays, cAMP Assays), By Applications (Cardiovascular System, Central Nervous System, Respiratory System, Immune System, Reproductive System, Oncology, Others), By Players/Companies Abcam plc, Abbott, Becton, Dickinson, EMD Millipore, Enzo Life Sciences, Inc., Thermo Fisher Scientific, Inc., Promega Corporation, Qiagen, PerkinElmer, Inc., HD Biosciences Co. Ltd., DiscoveRx Corporation, Cisbio Bioassays, AbbVie”.
Scope Of The Report
Report Attributes
Report Details
Report Title
G-protein Coupled Receptor Market Research Report
By Type
Calcium Level Detection Assays, GTP?S Binding Assays, cGMP Assays, Reporter Gene Assays, Receptor Internalization Assays, cAMP Assays
By Application
Cardiovascular System, Central Nervous System, Respiratory System, Immune System, Reproductive System, Oncology, Others
By Companies
Abcam plc, Abbott, Becton, Dickinson, EMD Millipore, Enzo Life Sciences, Inc., Thermo Fisher Scientific, Inc., Promega Corporation, Qiagen, PerkinElmer, Inc., HD Biosciences Co. Ltd., DiscoveRx Corporation, Cisbio Bioassays, AbbVie
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global G-protein Coupled Receptor Market Report Segments:
The global G-protein Coupled Receptor market is segmented on the basis of:
Types
Calcium Level Detection Assays, GTP?S Binding Assays, cGMP Assays, Reporter Gene Assays, Receptor Internalization Assays, cAMP Assays
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cardiovascular System, Central Nervous System, Respiratory System, Immune System, Reproductive System, Oncology, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abcam plc
- Abbott
- Becton, Dickinson
- EMD Millipore
- Enzo Life Sciences, Inc.
- Thermo Fisher Scientific, Inc.
- Promega Corporation
- Qiagen
- PerkinElmer, Inc.
- HD Biosciences Co. Ltd.
- DiscoveRx Corporation
- Cisbio Bioassays
- AbbVie
Highlights of The G-protein Coupled Receptor Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Calcium Level Detection Assays
- GTP?S Binding Assays
- cGMP Assays
- Reporter Gene Assays
- Receptor Internalization Assays
- cAMP Assays
- By Application:
- Cardiovascular System
- Central Nervous System
- Respiratory System
- Immune System
- Reproductive System
- Oncology
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the G-protein Coupled Receptor Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
G-protein coupled receptors (GPCRs) are a family of proteins that bind to specific molecules called G-proteins. When the GPCR is activated, it causes the release of chemicals called hormones from cells in the body.
Some of the major companies in the g-protein coupled receptor market are Abcam plc, Abbott, Becton, Dickinson, EMD Millipore, Enzo Life Sciences, Inc., Thermo Fisher Scientific, Inc., Promega Corporation, Qiagen, PerkinElmer, Inc., HD Biosciences Co. Ltd., DiscoveRx Corporation, Cisbio Bioassays, AbbVie.
The g-protein coupled receptor market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. G-protein Coupled Receptor Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. G-protein Coupled Receptor Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. G-protein Coupled Receptor Market - Supply Chain
4.5. Global G-protein Coupled Receptor Market Forecast
4.5.1. G-protein Coupled Receptor Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. G-protein Coupled Receptor Market Size (000 Units) and Y-o-Y Growth
4.5.3. G-protein Coupled Receptor Market Absolute $ Opportunity
5. Global G-protein Coupled Receptor Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. G-protein Coupled Receptor Market Size and Volume Forecast by Type
5.3.1. Calcium Level Detection Assays
5.3.2. GTP?S Binding Assays
5.3.3. cGMP Assays
5.3.4. Reporter Gene Assays
5.3.5. Receptor Internalization Assays
5.3.6. cAMP Assays
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global G-protein Coupled Receptor Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. G-protein Coupled Receptor Market Size and Volume Forecast by Application
6.3.1. Cardiovascular System
6.3.2. Central Nervous System
6.3.3. Respiratory System
6.3.4. Immune System
6.3.5. Reproductive System
6.3.6. Oncology
6.3.7. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global G-protein Coupled Receptor Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. G-protein Coupled Receptor Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global G-protein Coupled Receptor Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. G-protein Coupled Receptor Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global G-protein Coupled Receptor Demand Share Forecast, 2019-2029
9. North America G-protein Coupled Receptor Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America G-protein Coupled Receptor Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America G-protein Coupled Receptor Market Size and Volume Forecast by Application
9.4.1. Cardiovascular System
9.4.2. Central Nervous System
9.4.3. Respiratory System
9.4.4. Immune System
9.4.5. Reproductive System
9.4.6. Oncology
9.4.7. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America G-protein Coupled Receptor Market Size and Volume Forecast by Type
9.7.1. Calcium Level Detection Assays
9.7.2. GTP?S Binding Assays
9.7.3. cGMP Assays
9.7.4. Reporter Gene Assays
9.7.5. Receptor Internalization Assays
9.7.6. cAMP Assays
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America G-protein Coupled Receptor Demand Share Forecast, 2019-2029
10. Latin America G-protein Coupled Receptor Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America G-protein Coupled Receptor Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America G-protein Coupled Receptor Market Size and Volume Forecast by Application
10.4.1. Cardiovascular System
10.4.2. Central Nervous System
10.4.3. Respiratory System
10.4.4. Immune System
10.4.5. Reproductive System
10.4.6. Oncology
10.4.7. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America G-protein Coupled Receptor Market Size and Volume Forecast by Type
10.7.1. Calcium Level Detection Assays
10.7.2. GTP?S Binding Assays
10.7.3. cGMP Assays
10.7.4. Reporter Gene Assays
10.7.5. Receptor Internalization Assays
10.7.6. cAMP Assays
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America G-protein Coupled Receptor Demand Share Forecast, 2019-2029
11. Europe G-protein Coupled Receptor Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe G-protein Coupled Receptor Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe G-protein Coupled Receptor Market Size and Volume Forecast by Application
11.4.1. Cardiovascular System
11.4.2. Central Nervous System
11.4.3. Respiratory System
11.4.4. Immune System
11.4.5. Reproductive System
11.4.6. Oncology
11.4.7. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe G-protein Coupled Receptor Market Size and Volume Forecast by Type
11.7.1. Calium Level Detection Assays
11.7.2. GTP?S Binding Assays
11.7.3. cGMP Assays
11.7.4. Reporter Gene Assays
11.7.5. Receptor Internalization Assays
11.7.6. cAMP Assays
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe G-protein Coupled Receptor Demand Share, 2019-2029
12. Asia Pacific G-protein Coupled Receptor Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific G-protein Coupled Receptor Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific G-protein Coupled Receptor Market Size and Volume Forecast by Application
12.4.1. Cardiovascular System
12.4.2. Central Nervous System
12.4.3. Respiratory System
12.4.4. Immune System
12.4.5. Reproductive System
12.4.6. Oncology
12.4.7. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific G-protein Coupled Receptor Market Size and Volume Forecast by Type
12.7.1. Calcium Level Detection Assays
12.7.2. GTP?S Binding Assays
12.7.3. cGMP Assays
12.7.4. Reporter Gene Assays
12.7.5. Receptor Internalization Assays
12.7.6. cAMP Assays
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific G-protein Coupled Receptor Demand Share, 2019-2029
13. Middle East & Africa G-protein Coupled Receptor Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa G-protein Coupled Receptor Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa G-protein Coupled Receptor Market Size and Volume Forecast by Application
13.4.1. Cardiovascular System
13.4.2. Central Nervous System
13.4.3. Respiratory System
13.4.4. Immune System
13.4.5. Reproductive System
13.4.6. Oncology
13.4.7. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa G-protein Coupled Receptor Market Size and Volume Forecast by Type
13.7.1. Calcium Level Detection Assays
13.7.2. GTP?S Binding Assays
13.7.3. cGMP Assays
13.7.4. Reporter Gene Assays
13.7.5. Receptor Internalization Assays
13.7.6. cAMP Assays
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa G-protein Coupled Receptor Demand Share, 2019-2029
14. Competition Landscape
14.1. Global G-protein Coupled Receptor Market: Market Share Analysis
14.2. G-protein Coupled Receptor Distributors and Customers
14.3. G-protein Coupled Receptor Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abcam plc
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Abbott
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Becton, Dickinson
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. EMD Millipore
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Enzo Life Sciences, Inc.
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Thermo Fisher Scientific, Inc.
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Promega Corporation
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Qiagen
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. PerkinElmer, Inc.
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. HD Biosciences Co. Ltd.
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. DiscoveRx Corporation
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Cisbio Bioassays
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. AbbVie
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outloo